France · Delayed Price · Currency is EUR Novacyt Company Description
Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors.
It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine.
The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases.
It operates in the United Kingdom, France, Europe, the United States, the Asia Pacific, the Middle East, and Africa.
The company was incorporated in 2006 and is based in Le Vésinet, France.
Contact Details
Address: 131 Boulevard Carnot Le Vésinet, 78110 France | |
| Phone | 33 1 39 46 51 04 |
| Website | novacyt.com |
Stock Details
| Ticker Symbol | ALNOV |
| Exchange | Euronext Paris |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | GBP |
| ISIN Number | FR0010397232 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Lyn Dafydd Rees | Chief Executive Officer and Executive Director |
| Steve Gibson | Chief Financial Officer, Company Secretary and Director |
| Dr. Joanne Mason | Chief Scientific Officer and Director |
| Peter Coyne | Chief Operations Officer |
| Wendy Karban | Director of Human Resources |
| Paul Oladimeji | Group Head of Research & Development |